Inflation, Health Care Reform, and Translational Research

“It’s Health Care Costs, Stupid.” So says Ezekiel Emanuel, paraphasing James Carville, in a Feb 29, 2008 commentary in JAMA. Emanuel argues that expanding health care coverage to the uninsured will be impossible and unsustainable unless the health care system gets a handle on cost inflation.

What does this have to do with translational research? A lot. Most economists agree that new technologies are one of the largest drivers of health care cost inflation. Though unmentioned in Emanuel’s piece, any attempt to rein in cost inflation will need to address incentive structures in biomedical innovation. This would have major implications for translational research (for example, cost controls would adversely affect the ability of biotechnology firms to raise capital). (photocredit: Sister72, 2006)

2008 February 29 | Leave a comment | Tags: Economics

BibTeX

@Manual{stream2008-174,
    title = {Inflation, Health Care Reform, and Translational Research},
    journal = {STREAM research},
    author = {Jonathan Kimmelman},
    address = {Montreal, Canada},
    date = 2008,
    month = feb,
    day = 29,
    url = {https://www.translationalethics.com/2008/02/29/inflation-health-care-reform-and-translational-research/}
}

MLA

Jonathan Kimmelman. "Inflation, Health Care Reform, and Translational Research" Web blog post. STREAM research. 29 Feb 2008. Web. 25 Apr 2024. <https://www.translationalethics.com/2008/02/29/inflation-health-care-reform-and-translational-research/>

APA

Jonathan Kimmelman. (2008, Feb 29). Inflation, Health Care Reform, and Translational Research [Web log post]. Retrieved from https://www.translationalethics.com/2008/02/29/inflation-health-care-reform-and-translational-research/

Tweet this post

Inflation, Health Care Reform, and Translational Research

Leave a Reply Cancel reply

Search STREAM